Esophageal carcinoma

Cigarette smoke Bronchogenic carcinoma, esophageal, and bladder cancer... 

Rice TW, Boyce GA, Sivak MV, Adelstein DJ, Kirby TJ. Esophageal carcinoma esophageal ultrasound assessment of preoperative chemotherapy. Ann Thorac Surg 1992 53(6) 972-977. 

A 68-year-old man with alcoholic cirrhosis, hepatocellular carcinoma, esophageal varices, and hepatorenal syndrome was given intravenous boluses of terlipressin 1 mg qds and 3 days later developed diffuse purpuric necrotic plaques all over his body, including the tongue and scrotum. A week later the reticulated erythema of the trunk and the purpuric plaque on the scrotum became necrotic. He died 3 weeks later from staphylococcal septicemia. 

LRP1B Loss-of-function (sporadic) Esophageal squamous cell carcinoma, nonsmall-cell lung cancer... 

Ding Y, Shimada Y, Maeda M, et al. Association of CC chemokine receptor 7 with lymph node metastasis of esophageal squamous cell carcinoma. Clin Cancer Res 2003 9 3406-3412. 

Koyama, S., Maruyama, T., and Adachi, S. (1999). Expression of epidermal growth factor receptor and CD44 splicing variant sharing exons 6 and 9 on gastric and esophageal carcinomas a two flow-cytometric analysis. J. Cancer Res. Clin. Oncol. 125, 47—54. 

JMJD2A JMJD2C is amplified in esophageal squamous carcinomas and in desmoblastic JMJD2B medulloblastomas. 

Mice fed 0, 5, 25, or 100ppm B[[Pg.77]

Coia LR, Engstrom PF, Paul AR, et al. Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991 20 29-36. 

Burmeister BH, Denham JW, O Brien M, et al. Combined modality therapy for esophageal carcinoma preliminary results from a large Australasian multicenter study. Int J Radiat Oncol Biol Phys 1995 32(4) 997-1006. 

Thirion P, Piedbois Y, Adelstein DJ. (2001). Preoperative Chemoradiotherapy Using Taxanes for Locally Advanced Esophageal Carcinoma. J Clin Oncol 2001 19 1880-1882. 

Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998 83(10) 2049-2053. 

Heidemann J, Schilling MK, Schmassmann A, Maurer CA, Buchler MW. Accuracy of endoscopic ultrasonography in preoperative staging of esophageal carcinoma. Dig Surg 2000 17(3) 219—224. 

Flamen P, Lerut A, Van Cutsem E, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000 18(18) 3202—3210. 

Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg 1992 16(6) 1104—1109. 

Wang M, Gu XZ, Yin WB, Huang GJ, Wang LJ, Zhang DW. Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of esophageal carcinoma report on 206 patients. Int J Radiat Oncol Biol Phys 1989 16(2)325-327. 

Arnott SJ, Duncan W, Gignoux M, et al. Preoperative radiotherapy in esophageal carcinoma a metaanalysis using individual patient data (Oesophageal Cancer Collaborative Group). Int J Radiat Oncol Biol Phys 1998 41(3)379-583. 

Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001 19(2) 305-313. 

Hoff SJ, Stewart JR, Sawyers JL, et al. Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. Ann Thorac Surg 1993 56(2) 282-286. 

Mendenhall WM, Sombeck MD, Parsons JT, Kasper ME, Stringer SP, Vogel SB. Management of Cervical Esophageal Carcinoma. Semin Radiat Oncol 1994 4(3) 179—191. 

Roussel A, Jacob JH, Haegele P, et al. Controlled clinical trial for the treatment of patients with inoperable esophageal carcinoma a study of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Recent Results Cancer Res 1988 110 21-29. 

Zimmermann KC, Sarbia M, Weber AA, et al. Cyclooxygenase-2 expression in human esophageal carcinoma. Cancer Res 1999 59 198-204. 

Lerut et al. prospectively included 42 patients in a staging study of esophageal carcinoma [77]. All patients underwent [ F]-FDG-PET, CT and EUS. For the diagnosis of regional lymph node metastases [ F]-FDG-PET was not considered to be useful because of a lack of sensitivity, which was 22% compared with 83% for CT and EUS. 

---